The World Health Organisation (WHO) agrees that the anti-counterfeit legislation that has been adopted or that is under consideration in East Africa threatens the accessibility of affordable generic medicines according to this report published by IPS Inter Press Sevice. The report follows the recent Kenyan case kindly reported by John Syekei here. Afro-IP generated some helpful comments from co-blogger Paul Asiimwe and others here, one of which was that the Kenyan definition of "counterfeiting" was almost identical to the WHO definition (WHO site -here). Afro Leo has not had the opportunity to compare the texts and would welcome views. Does the WHO admit that its template legislation is flawed?
ABOUT THE EDITOR
Firi Abibirem, da biara asɛm foforɔ.
Popular Posts
-
From the AGIP July Bulletin (published by Abu-Ghazaleh Intellectual Property) comes this news about the .AFRICA generic top-level domain (... -
Van's Aircraft is a very successful producer of experimental aircraft and aircraft kits based in the US. Their fleet of RVs (as they ar... -
Using RSA as an example, this post makes a case for a more simplified approach to the trade mark infringement test. It recommends that the ... -
INTRODUCTION When a trade mark rights holder (statutory/common law), is estopped, on the way to the forum, or anywhere else, from act... -
Last week I spent time in Botswana for a hearing. It also gave me an opportunity to pilot my first international flight. It’s a wonderful th...
IPKAT APPROVED
